Recurrent Merkel Cell Carcinoma
5 clinical trials · Condition
◉ Watch Recurrent Merkel Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors (NCT03074513) | M.D. Anderson Cancer Center | 2017-03-03 |
| Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer (NCT02267603) | National Cancer Institute (NCI) | 2014-11-25 |
| Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma (NCT01758458) | Fred Hutchinson Cancer Center | 2013-02-01 |
| Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma (NCT01204476) | National Cancer Institute (NCI) | 2010-10-01 |
Track Recurrent Merkel Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.